Assignee
ADC THERAPEUTICS SA
CH14 patents
Top patents by PatentIndex Score
US11160872B2Nov 2, 2021
Pyrrolobenzodiazepine-antibody conjugates
ADC THERAPEUTICS SA2 citations73
US9828426B2Nov 28, 2017
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
ADC THERAPEUTICS SA3 citations71
US10780096B2Sep 22, 2020
Pyrrolobenzodiazepine-antibody conjugates
ADC THERAPEUTICS SA7 citations69
US10544223B2Jan 28, 2020
Combination therapy with an anti-axl antibody-drug conjugate
ADC THERAPEUTICS SA5 citations68
US11596696B2Mar 7, 2023
Combination therapy with an anti-CD25 antibody-drug conjugate
ADC THERAPEUTICS SA3 citations66
US11318211B2May 3, 2022
Dosage regimes for the administration of an anti-CD19 ADC
ADC THERAPEUTICS SA4 citations66
US11813335B2Nov 14, 2023
Pyrrolobenzodiazepine-antibody conjugates
ADC THERAPEUTICS SA0 citations62
US11484606B2Nov 1, 2022
Pyrrolobenzodiazepine-antibody conjugates
ADC THERAPEUTICS SA0 citations62
US11084872B2Aug 10, 2021
Method for treating breast cancer
ADC THERAPEUTICS SA0 citations61
US11976122B2May 7, 2024
Anti-IL13Rα2 antibodies
ADC THERAPEUTICS SA0 citations59
US11426467B2Aug 30, 2022
Dosage regimes for the administration of an anti-CD25 ADC
ADC THERAPEUTICS SA1 citations58
US11938192B2Mar 26, 2024
Dosage regimes for the administration of an anti-CD19 ADC
ADC THERAPEUTICS SA1 citations55
US11384098B2Jul 12, 2022
Pyrrolobenzodiazepine-antibody conjugates
ADC THERAPEUTICS SA0 citations52
US10597450B2Mar 24, 2020
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
ADC THERAPEUTICS SA0 citations51